Shock Clinical Trial
Official title:
Strong Ion Gap as Prognostic Indicator for Adult Patients Admitted With Shock to the Intensive Care Units
This study evaluates if strong ion gap on admission or 24 hours after admission to critical care unit can predict 28 day outcome in patients admitted with shock due to any cause
Metabolic acidosis is frequently found in patients with shock. Traditional methods of
evaluating acid-base status can underestimate and even miss complex acid-base disorders
particularly in the setting of hypoalbuminemia, hypo/hypernatraemia and hypo/hyperchloraemia
.An alternative approach to acid-base balance, based on chemical and physical principles, and
was proposed by Peter Stewart more than 30 years ago. Later in 1992 Figge and Fencl modified
the strong ion difference, which corresponds with the net charge balance of all strong ions
present in a given solution (the ''Fencl-Stewart'' approach). The strong ion gap (SIG) which
corresponds with the difference between the apparent strong ion difference and the effective
strong ion difference was proposed by Kellum. Compared to the Fencl- Stewart approach SIG has
more accuracy and bedside practicality.
As the SIG is calculated from all known charged components of blood, it is considered the
gold standard for the quantification of unmeasured anions. In contrast, the traditional anion
gap calculation only factors in sodium, potassium, chloride and bicarbonate. In healthy
humans, the SIG equals zero. In critically ill patients, a high SIG, defined as >2mEq/L,
indicates the accumulation of unmeasured anions in blood as a cause of acidosis. The
unmeasured anions include lactate, ketoacids, uraemic acids and toxins like ethylene glycol
and methanol. Studies found that a higher SIG on admission to intensive care unit is
associated with poorer outcomes, and has a role in prediction of outcome in septic patients.
However this finding is not consistent.
In addition it was found that there is a significant difference in the threshold for SIG
value associated with higher mortality. The abnormal SIG value in American studies are
described around 5 mEq/l . However studies from Europe and Australia reported higher values
in the range of 8-13 mEq/l. It is speculated that this difference is due to exogenous sources
of unmeasured ions from gelatin based intravenous fluids used for resuscitation.
Interestingly studies using gelatine- based fluids also failed to show a correlation between
SIG and mortality. SIG values have not been published in critically ill Asian adult patients
admitted to the Intensive Care Units (ICU) as yet. We aim to find the SIG for these patients
in the hope that it will be useful for predicting outcome. Our hypothesis is that SIG is an
independent predictor of outcomes in adult patient with shock.
We propose to conduct this prospective observational study in the surgical and medical ICUs
of 2 hospitals in Singapore. (Singapore General Hospital and Changi General Hospital) We aim
to enrol 112 of you admitted to the ICU with shock of any etiology. Shock is defined as
persistence of arterial hypotension despite adequate volume resuscitation. Hypotension is
defined as systolic pressure <90mmHg, Mean arterial pressure (MAP)<70 mmHg or drop in SBP >40
mmHg from baseline. 30ml/kg of fluid is considered as the threshold for adequate volume
resuscitation.
The methodology of this observational study was approved by Sing health Institutional review
Board, Singapore. We will include you if you have persistent hypotension despite adequate
fluid resuscitation as defined above or if you require vasopressors or inotropes to maintain
MAP above 65mmHg on admission.
We will exclude the conditions with acid base disturbance which are not amenable to using
standard supportive care such as pre-existing chronic kidney disease stage 3 and above (
defined as estimated GFR<60 ml/min/1.73m2 ) and chronic liver failure.
Blood samples will be taken from indwelling intra-arterial catheters on admission and 24
hours after admission. Blood samples will be analyzed in the respective hospital laboratory
for Arterial Blood Gas(ABG) analysis, electrolytes albumin and lactate levels in order to
calculate the SIG.
All of you included in the study will be managed by the same group of critical care physician
in accordance with pre-existing protocols in both ICUs to ensure that there will not be any
major discrepancies among patients in terms of organ support and therapy. Haemodynamic
support will be applied to reverse the hypotension and to correct peripheral perfusion
abnormalities after optimal resuscitation. IV noradrenaline is the vasopressor of first
choice followed by vasopressin and adrenaline.
Data collection-
Fluid resuscitation before ICU admission, SOFA and APACHE II score 24 hours after the
admission, requirement for vasopressors, mechanical ventilation renal replacement
therapy(RRT) ,duration of ICU stay, number of ventilator days, duration of vasopressor
support, number of vasopressors used and the duration of RRT, 28 day outcome will be
collected.
Calculation of SIG-
SIG will be calculated according to the following formulae;
1. SIG= SIDapp - SIDeff
(SIDapp -Strong ion difference apparent; SIDeff - Strong ion difference effective)
2. SIDapp = ( Na++K++Ca2++Mg2+) - (Cl-+Lactate-)
( all concentrations in mEq/l)
3. SIDeff = 2.46 x 10-8 x Pco2/ 10-pH + [albumin] x ( 0.123xpH - 0.631) +[PO43-] x
(0.309xpH -0.469)
(PCO2 is measured in mm Hg, albumin in g/L, and phosphate in mmol/L)
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05563701 -
Evaluation of the LVivo Image Quality Scoring (IQS)
|
||
Recruiting |
NCT05066256 -
LV Diastolic Function vs IVC Diameter Variation as Predictor of Fluid Responsiveness in Shock
|
N/A | |
Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
Terminated |
NCT02755155 -
Optimization of Therapeutic Human Serum Albumin Infusion in Selected Critically Ill Patients
|
Phase 4 | |
Not yet recruiting |
NCT01941472 -
Transcutaneous pO2, Transcutaneous pCO2 and Central Venous pO2 Variations to Predict Fluid Responsiveness
|
N/A | |
Terminated |
NCT01696175 -
PICU Admission Lactate and Central Venous Oxymetry Study
|
N/A | |
Completed |
NCT01680783 -
Non-Invasive Ventilation Via a Helmet Device for Patients Respiratory Failure
|
N/A | |
Recruiting |
NCT01174966 -
Assessment of Transcutaneous Oxygen Tension/Oxygen Challenge Test in Intensive Care Unit (ICU) Patients
|
N/A | |
Recruiting |
NCT01157299 -
Hemodynamic Evaluation of Preload Responsiveness in Children by Using PiCCO
|
N/A | |
Completed |
NCT00743522 -
Programming Implantable Cardioverter Defibrillators in Patients With Primary Prevention Indication
|
||
Completed |
NCT03296891 -
Point of Care Ultrasonography In The Management of Shock: A Pilot Study
|
N/A | |
Not yet recruiting |
NCT05922982 -
Norepinephrine Weaning Guided by the Hypotension Prediction Index in Vasoplegic Shock After Cardiac Surgery
|
N/A | |
Withdrawn |
NCT04705701 -
Comparing Post Cardiac Surgery Outcomes in ESRD Patient's With Early Dialysis Versus Standard Care
|
N/A | |
Recruiting |
NCT04615065 -
Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine
|
||
Completed |
NCT05330676 -
Evaluation of Microcirculatory Function and Mitochondrial Respiration After Cardiovascular Surgery
|
||
Active, not recruiting |
NCT04079829 -
Postoperative Respiratory Abnormalities
|
||
Completed |
NCT04089098 -
VOLume and Vasopressor Therapy in Patients With Hemodynamic instAbility
|
||
Completed |
NCT03190408 -
Variation in Fluids Administered in Shock
|
||
Completed |
NCT05193123 -
Psychological Trauma and Resilience After Critical Illness
|
||
Recruiting |
NCT05092165 -
Methylene Blue for the Prevention of Hypotension During Hemodialysis
|
Phase 2 |